Barclays’s Psychemedics Corporation PMD Stock Holding History

Barclays’s Portfolio PMD Stock Details PMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-38	Closed	–	–	6905
2019 Q3	$0	Buy	+38	New	+$323	﹤0.01%	7220
2018 Q4	–	Sell	-4	Closed	–	–	7429
2018 Q3	$0	Buy	+4	New	+$80	﹤0.01%	7454
2017 Q3	–	Sell	-814	Closed	-$20K	–	7095
2017 Q2	$20K	Buy	814 +366	+82%	+$7.69K	﹤0.01%	5800
2017 Q1	$9K	Buy	+448	New	+$9.83K	﹤0.01%	6122

Other funds holding PMD

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

TCM

Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return

CIC

Crawford Investment Counsel Atlanta, Georgia $5.85B AUM 12.61% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Barclays's PMD Position: Q4 2019 in Review

Barclays sold out of Psychemedics Corporation (PMD) in Q4 2019, closing a stake of 38 shares.

Barclays first reported a position in PMD in Q1 2017 and held it in 4 quarters. The position peaked at $20K in Q2 2017. 42 funds tracked by Wall St. Rank hold PMD as of Q4 2019.

Barclays reported no remaining Psychemedics Corporation position as of Q4 2019 after selling out during the quarter.
Barclays sold 38 Psychemedics Corporation shares in Q4 2019.
Barclays first reported a position in Psychemedics Corporation in Q1 2017 and held it in 4 quarters.
Barclays's Psychemedics Corporation position peaked at $20K in Q2 2017.
42 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q4 2019.

Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.